{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P03372",
      "entity_text" : "estrogen receptor",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5035",
      "entity_text" : "raloxifene",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Selective estrogen receptor modulators (SERMs) such as raloxifene, lasofoxifene and bezedoxifene are useful as second-line agents in postmenopausal women with osteoporosis who are unsuitable candidates for the use of bisphosphonate [XREF_BIBR].",
  "reading_complete" : "2020-08-02T12:23:42Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T12:16:31Z",
  "trigger" : "modulators",
  "evidence" : [ "estrogen receptor modulators (SERMs) such as raloxifene" ],
  "pmc_id" : "4319192",
  "score" : 0
}